← Back to Search

Topical Analgesic

Capsaicin 8% Patch for Neuropathic Pain (Capsaicin Trial)

N/A
Waitlist Available
Led By Michelle Trbovich, MD
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in pain at 2,4,6,8, 10 and 12 weeks
Awards & highlights

Capsaicin Trial Summary

This trial will study how well and how long 8% capsaicin patches work to relieve neuropathic pain in people with spinal cord injuries.

Eligible Conditions
  • Neuropathic Pain
  • Spinal Cord Injury

Capsaicin Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in pain at 2,4,6,8, 10 and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in pain at 2,4,6,8, 10 and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Pain Relief With Visual Analog (VAS) Pain Scale
Change in Quality of Life as Measured by the World Health Organization Quality of Life (WHOQOL-BREF)
Spinal Cord

Side effects data

From 2016 Phase 4 trial • 120 Patients • NCT03124407
65%
Application site pain
18%
Application site pruritus
3%
Application site erythema
100%
80%
60%
40%
20%
0%
Study treatment Arm
QD-Active
QD-Vehicle
BID-Active
BID-Vehicle

Capsaicin Trial Design

2Treatment groups
Experimental Treatment
Group I: Investigational Capsacin, Then Control CapsacinExperimental Treatment2 Interventions
Qutenza, Capsaicin 8% Patch will be used for 12 weeks followed by capsacin 0.025% Well Patch
Group II: Control Capsacin, Then Investigational CapsacinExperimental Treatment2 Interventions
Active control with low dose capsaicin 0.025% Well Patch used for 12 weeks followed by Qutenza 8% Patch
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low Dose Capsaicin 0.025% Well Patch
2016
N/A
~20
Capsaicin
FDA approved

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor
452 Previous Clinical Trials
91,403 Total Patients Enrolled
Michelle Trbovich, MDPrincipal InvestigatorSouth Texas Veterans Health Care System
1 Previous Clinical Trials
20 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025